AK112 and Cadonilimab Combined With Chemotherapy for 1L Treatment of Metastatic Pancreatic Cancer
Clinical trial NCT06646055 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06646055
- Sponsor
- Akeso
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-21
- Primary completion
- 2026-12-30
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.